ATEK vs. OMCL, MDRX, HSTM, CRTX, FRLA, YOTA, WINV, WAVS, GDST, and AOGO
Should you be buying Athena Technology Acquisition stock or one of its competitors? The main competitors of Athena Technology Acquisition include Omnicell (OMCL), Veradigm (MDRX), HealthStream (HSTM), Cortexyme (CRTX), Fortune Rise Acquisition (FRLA), Yotta Acquisition (YOTA), WinVest Acquisition (WINV), Western Acquisition Ventures (WAVS), Goldenstone Acquisition (GDST), and Arogo Capital Acquisition (AOGO).
Athena Technology Acquisition vs.
Athena Technology Acquisition (NYSE:ATEK) and Omnicell (NASDAQ:OMCL) are both unclassified companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, community ranking, analyst recommendations, dividends, earnings and institutional ownership.
17.3% of Athena Technology Acquisition shares are owned by institutional investors. Comparatively, 97.7% of Omnicell shares are owned by institutional investors. 88.4% of Athena Technology Acquisition shares are owned by insiders. Comparatively, 2.6% of Omnicell shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
In the previous week, Omnicell had 2 more articles in the media than Athena Technology Acquisition. MarketBeat recorded 2 mentions for Omnicell and 0 mentions for Athena Technology Acquisition. Omnicell's average media sentiment score of 1.10 beat Athena Technology Acquisition's score of 0.34 indicating that Omnicell is being referred to more favorably in the news media.
Athena Technology Acquisition has a net margin of 0.00% compared to Omnicell's net margin of -1.66%. Omnicell's return on equity of 2.55% beat Athena Technology Acquisition's return on equity.
Athena Technology Acquisition has higher earnings, but lower revenue than Omnicell.
Athena Technology Acquisition has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500.
Athena Technology Acquisition received 133 more outperform votes than Omnicell when rated by MarketBeat users. However, 66.89% of users gave Omnicell an outperform vote while only 63.65% of users gave Athena Technology Acquisition an outperform vote.
Omnicell has a consensus target price of $50.00, indicating a potential upside of 17.38%. Given Omnicell's stronger consensus rating and higher possible upside, analysts clearly believe Omnicell is more favorable than Athena Technology Acquisition.
Summary
Omnicell beats Athena Technology Acquisition on 11 of the 14 factors compared between the two stocks.
Get Athena Technology Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEK and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Athena Technology Acquisition Competitors List
Related Companies and Tools
This page (NYSE:ATEK) was last updated on 1/22/2025 by MarketBeat.com Staff